Dr. Eduardo B. Fernandez

  • Radiation Oncologist
  • Spoken languages English, Spanish


Eduardo Fernandez serves as Chairman of the Board of Chancellors for the American College of Radiation Oncology. He has published two doctoral theses as well as numerous book chapters and articles. He has lectured in more than 100 topics all over the world. He has been recognized by the Florida Medical Association as Distinguished Physician and the Florida Diversity Council with the Multicultural Leadership Award. Dr. Fernandez is a fellow of the American College of Radiation Oncology and the American Society for Therapeutic Radiation Oncology. He is also on faculty at U.C.L.A. where he serves as Assistant Professor in Radiation Oncology. Dr. Fernandez has been a member of GenesisCare since 1998, with numerous administrative roles and currently is the Medical Director of the International Program.

Career Positions

Current position(s)

  • GenesisCare - National Medical Director, Plantation, FL

Past position(s)

  • American College of Radiation Oncology - Vice President and Board of Chancellors
  • Aventura Hospital - Chief of Radiation Oncology, Aventura, FL
  • Cleveland Clinic Florida - Head of Radiation Oncology, Dual Appointment at Main Campus of Cleveland Clinic Foundation, Weston, FL



  • University of Malaga (European Union), PhD, Malaga, Spain
  • University of Malaga (European Union), Doctor of Medicine, Malaga, Spain


  • Cleveland Clinic Foundation, Radiation Oncology, Cleveland, OH


  • Cleveland Clinic Foundation, Medical, Surgical, Cleveland, OH

Expertise And Interests


  • Prostate, Breast, Lung, Colorectal, Head and Neck, Brain and Spine Tumors


Awards and honors

  • Multicultural Leadership Award - Florida Diversity Council; Honorary Member of the Radiation Therapy Society of the Dominican Republic; Leader in Medicine Award - Florida Medical Association; Distinguished Physician - Florida Medical Association; Two doct


  • Protection by Fluoride against Phthalocyanine induced photodynamic killing of Chinese Hamster Cells
  • Comparative Study of Ion F-Mediated Inhibition on Nuclear DNA Photodynamic Damage Induced by Dihematoporphyryn Ether and Chloro-aluminum-phthalocyanine in V-79 Cells
  • Analysis of Toxicity In a Group of Patients Treated for Pancreatic Cancer with Combined Modality 3-D Radiation Therapy
  • Photodynamic Action of Siloxiphthalocyanine in V-79 Cells
Expand Publications
View 2 more



Dioval A. Remonde, BS, Ron R. Allison,MD, Sharon A. Salenius, MPH, Andrej Hnatov, MD, Cynthia Ballenger, MD, Constantine A. Mantz, MD, Eduardo Fernandez,MD,PhD, Steven E. Finkelstein,MD, 2015, ARS

View Presentation


Francisco A. Myslicki, Jesse Shulman, Sharon Salenius, Neal Shore, Constantine Mantz, Eduardo Fernandez, Steven E. Finkelstein, 20158, ARS

View Presentation


Lacombe J, McClain K, Gonzales P, Fernandez E, Galmarini D, Dosoretz D, Zenhausern F, Finkelstein SE., 2016, ACRO

View Presentation


E. Arrojo, E. Fernandez, L. Kestin, A. Martinez., 2016, ACRO

View Presentation


Finkelstein SE, Salenius S, Cross CK, Allison RR, Shafman T, Mantz C, Fernandez E, 2016, ASCO

View Presentation


Finkelstein SE, Forman J, Fernandez E, Chen C, Lieberfarb M, Salenius SA, Shafman T, and Mantz CA, 2016, ASTRO

View Presentation


Martinez A, Olivera G, Ghilezan M, Forman J, Kestin L, Finkelstein S, Mo X, Key S, Mantz C, Fernandez E, Galmarini D, et al., 2015, ASTRO Annual Meeting

View Presentation


Myslicki FA, Salenius SA, Rotterman YW, Mantz CA, Finkelstein SE, Fernandez E., 2015, ACRO Annual Meeting

View Presentation


Allison R, Salenius SA, Hnatov A, Ballenger D, Lichtblau D, Mantz CA, Fernandez E, Finkelstein SE, 2015, ASTRO Annual Meeting

View Presentation


Kestin L, Fernandez E, Mantz C, Olivera G, Mo X, Key S, Finkelstein SE, Martinez A, Galmarini D., 2015, ASTRO Annual Meeting

View Presentation


A. Ahamad, S. Salenius, R. Ross, E. Fernandez, 2016, ASTRO

View Presentation


Anesa W. Ahamad, Sharon Salenius, Chaundre K. Cross, Ron R. Allison, Eduardo B. Fernandez, 2016, ACRO

View Presentation


Mantz Constantine, Wallner Paul, Fernandez Eduardo B., Salenius Sharon, 2017, AAPM Spring Clinical Meeting

View Presentation


Ron R. Allison, Sharon A. Salenius, Andrej Hnatov, Cynthia Ballenger, Anesa Ahamad, Constantine A. Mantz, Eduardo Fernandez, Steven E. Finkelstein, 2016, American Radium Society 100th Anniversary Meeting

View Presentation


Anesa Ahamad, Donald Weed, Darel Pruett, Daniel Saulpaugh, Eduardo Fernandez, 2016, American Radium Society’s 100th Anniversary Meeting

View Presentation


Myslicki FA, Salenius SA, Shore ND, Mantz CA, Fernandez E, Finkelstein SE, 2015, ACRO Annual Meeting

View Presentation
Expand Presentations
View 14 more

Clinical studies

Primary Objective The primary goal of this study is to determine whether, in men with postprostatectomy PSA (prostate specific antigen) recurrences with aggressive disease features, salvage radiotherapy (SRT) with enhanced androgen deprivation therapy (ADT), consisting of enzalutamide (MDV3100) and a GnRH analog, will improve progression-free survival compared to SRT with standard GnRH analog -based ADT.

View Study

Eduardo Fernandez-Vicioso's Reviews


based on 84 Ratings 15 Comments


Explain a little more about the different types of radiation that can be used to treat my cancer


I understand there was a change in ownership of the company to Genesis Care from one day to the next, when I was there, however, I would have appreciated a shorter timeframe from the day of simulation to the beginning of treatment, if that could have been possible.


respect for the patient, take the time to answer all questions, give all the informations , prompt and friendly, adequate office intallations.


Dr. Fernandez is the nicest doctor. Reviews everything he's call you back when he says he's going to call you back but staff is very polite. I've been in a lot of doctor's office and Dr. Fernandez his staff is one of the politest office I've ever been in. I think the whole office is great. I can't think of anything they can improve on.

Read More

Ratings and Comments Powered by NRC Health